Binting, Elsa M.

HRN: 18-66-33  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/20/2023
CEFTRIAXONE 1G (VIAL)
01/20/2023
01/26/2023
IV
2g
Q24H
Acute Complicated Urinary Tract Infection
Waiting Final Action 
05/30/2023
CEFTRIAXONE 1G (VIAL)
05/30/2023
06/07/2023
IV
2g
OD
Empiric
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: